American College of Neuropsychopharmacology

What American College of Neuropsychopharmacology does

The American College of Neuropsychopharmacology (ACNP) is a 501(c)(3) non-profit professional society founded in 1961 and headquartered in Brentwood, Tennessee. Its stated purpose is to advance the scientific understanding of disorders of the brain and behavior and to facilitate communication about their prevention and treatment. ACNP serves an international membership of academic researchers, clinical practitioners, early-career scientists, and pharmaceutical industry participants through a portfolio built around the annual scientific meeting (the 65th edition scheduled for January 10-13, 2027, in San Diego), three peer-reviewed journals (Neuropsychopharmacology, co-published with Nature Publishing Group; NPP Reviews; and NPP-Digital Psychiatry and Neuroscience, launched in 2023), and an extensive digital library of bulletins, education presentations, podcasts, and oral histories housed in partnership with UCLA's Louise M. Darling Biomedical Library.

Revenue is generated through four principal streams: annual membership dues across Member, Fellow, Emeritus, and Associate tiers; publication royalties from journal sales; meeting registration fees including a $40 CME-credit surcharge; and corporate grants and government funding administered under formal conflict-of-interest policies. ACNP also operates a Corporate Partnership Program drawing in pharmaceutical and biotechnology sponsors including AbbVie, ACADIA Pharmaceuticals, and Alkermes, and engages Amedco LLC for joint accreditation of continuing medical education credits. Operations and platform management are delegated to Parthenon Management Group, LLC under the Terms of Use agreement.

Distribution is member-gated: access to the journal portfolio, member directory, meeting content, and member documents flows through the acnp.org member portal, with annual meeting registration conducted via the SocietyConference platform. Members include physicians, nurse practitioners, physician assistants, postdoctoral fellows, residents on research tracks, and faculty, supported by career-transition mentoring, near-peer mentorship, travel awards, honorific awards, global scholarships, and early-stage investigator assistance. Membership is selective, with invitations distributed through General and Special Invitation Banks capped at 50 and 150 slots respectively per meeting, reinforcing the society's positioning as a high-prestige, invitation-based scientific forum rather than a mass-membership organization.

Name

American College of Neuropsychopharmacology

Legal name

American College of Neuropsychopharmacology

Website

https://acnp.org

Company type

Private

Founded year

1961

Operating status

Operating

Short description

The American College of Neuropsychopharmacology is a 501(c)(3) non-profit professional society founded in 1961 that advances the scientific understanding of brain and behavior disorders through an invitation-based annual meeting, three peer-reviewed journals, and a member-gated digital library, serving credentialed researchers, clinicians, early-career scientists, and pharmaceutical sponsors.

Ownership category

akta.pro rank

Product category

Professional Medical Society / Scientific Membership Organization

NAICS

Colleges, Universities, and Professional Schools (6113)

SIC

Services-Educational Services (8200)

akta.pro industry

PRIMARYEDAGANAJ

Healthcare & Clinical Professional Development (CME/CE)

Education/Educational Publishing & Learning Content/Professional Development & Training Materials

Keywords

• Neuropsychopharmacology research
• Professional medical society
• Scientific publications
• Continuing medical education
• Annual scientific meeting

Headquarters

HQ city

Brentwood

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Others, Marketing or Sales, Technology or R&D

Revenue model

1. Membership Dues: Annual membership dues from Members, Fellows, Emeritus members, and Associate Members who pay to join the professional society and gain access to meetings, publications, and networking.
2. Publication Royalties: Royalties from the sale of publications including the Neuropsychopharmacology journal, NPP Digital Psychiatry and Neuroscience, NPP Reviews, and book series (4th and 5th Generation).
3. Meeting Registration Fees: Registration fees charged for the Annual Meeting, which includes options for in-person attendance and recordings-only access. A $40 fee is charged for CME credits.
4. Corporate Grants and Funding: Grants and funding from pharmaceutical corporations and government agencies. The college has established policies to manage conflicts of interest and maintain operational independence from sponsors.

Pricing tiers

Distribution channels3 records

Marketing channels6 records

Core offering

The American College of Neuropsychopharmacology (ACNP) is a non-profit professional medical society that delivers scientific exchange, peer-reviewed publications, and career development for the neuropsychopharmacology community. Its core offerings are the Annual Meeting (the 65th scheduled for January 10-13, 2027, in San Diego), three peer-reviewed journals (Neuropsychopharmacology with Nature, NPP-Digital Psychiatry and Neuroscience, and NPP Reviews), a Digital Library of educational content, and tiered membership (Member, Fellow, Emeritus, Associate) with continuing medical education credits.

Product overview

The American College of Neuropsychopharmacology (ACNP) operates as a professional membership society rather than a technology company. Its core offerings consist of the Annual Meeting (the 65th scheduled for January 2027 in San Diego), three peer-reviewed journals (Neuropsychopharmacology published with Nature, NPP-Digital Psychiatry and Neuroscience launched in 2023, and NPP Reviews), a Digital Library containing educational presentations, podcasts, bulletins and oral histories, membership services with Fellow/Member/Emeritus tiers, and career development resources including travel awards, mentorship programs, and grants. The organization also manages continuing medical education accreditation through Amedco LLC.

Differentiator

Problem solved

Functional benefit

Brands

• Neuropsychopharmacology (NPP): The official journal of the ACNP, published by Nature Publishing Group, covering original neuroscience and clinical research on psychopharmacology and related disciplines.
• NPP-Digital Psychiatry and Neuroscience
• NPP Reviews
• Neuropsychopharmacology 5th Generation (Book)
• Psychopharmacology 4th Generation Progress (Book)

Products and services

• ACNP Annual Meeting The flagship Annual Meeting is one of the world's leading forums for the exchange of cutting-edge scientific information about the brain, behavior, and psychotropic drugs, offering scientific programs in clinical and basic research and the opportunity to interact with internationally distinguished researchers. It is open primarily to Members, Fellows, Emeritus members, and invited guests (with up to 400 member invited guest invitations and up to 50 General Invitation Bank plus 150 Special Invitation Bank invitations available).
• Neuropsychopharmacology (NPP) Journal

Quantifiable outcome

• Up to 25.0 live AMA PRA Category 1 Credits and 99.75 enduring credits available for healthcare professionals at the Annual Meeting
• +1 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and minor.

• Nature Publishing GroupcoreStrategic or Co-development PartnerACNP's official journal Neuropsychopharmacology is published by Nature. This partnership provides the primary academic publication platform for the organization's scientific content and research dissemination.
• AbbVieminorOthersPharmaceutical corporation participating in the ACNP Corporate Partnership Program, providing funding support to the organization.
• ACADIA Pharmaceuticals Inc.minorOthersPharmaceutical corporation participating in the ACNP Corporate Partnership Program, providing funding support to the organization.
• AlkermesminorOthersPharmaceutical corporation participating in the ACNP Corporate Partnership Program, providing funding support to the organization.
• Amedco LLCcoreOthersACNP's Annual Meeting is jointly accredited by Amedco LLC, which is accredited by ACCME, ACPE, and ANCC to provide continuing education for healthcare professionals. This partnership enables CME credit issuance.
• American Psychiatric AssociationcoreStrategic or Co-development PartnerACNP collaborates with APA on the Future DSM Candidate Biomarkers and Biological Factors Repository Survey, working with APA's subcommittee to survey the field on potential biomarkers and biological factors involved in psychiatric disorders.
• UCLA Louise M. Darling Biomedical LibrarycoreStrategic or Co-development PartnerACNP Archives are housed at UCLA's Louise M. Darling Biomedical Library since 2008. Historians Joel Braslow and Marcia Meldrum and archivist Russell Johnson manage the archives, which include significant papers in neuropsychopharmacology history.
• Parthenon Management Group, LLCcoreOthersParthenon Management Group manages the ACNP website, platform operations, and provides meeting management services according to the Terms of Use agreement.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• American Psychiatric Association: APA is the largest professional psychiatric society in the U.S. and a direct peer to ACNP in mission—advancing psychiatric science and clinician education. ACNP collaborates with APA on the Future DSM Biomarkers project, underscoring deep scientific and operational overlap in neuropsychopharmacology education and policy.
• Society of Biological Psychiatry: SOBP is a closely aligned professional society focused on biological psychiatry, sharing substantial scientific overlap with ACNP's neuropsychopharmacology mission. Both organizations target psychiatrist-researchers and convene annual scientific meetings with peer-reviewed publication programs.
• European College of Neuropsychopharmacology: ECNP is ACNP's European counterpart in mission and structure, both being invitation-inclusive societies advancing neuropsychopharmacology research and education. The two organizations are the dominant professional societies in their respective geographies for the specialty.
• International College of Neuropsychopharmacology: CINP is a global professional society dedicated to neuropsychopharmacology with a mission nearly identical to ACNP's. Both organizations convene scientific meetings, support member research, and publish in the psychopharmacology domain, making CINP a direct international peer.
• British Association for Psychopharmacology: BAP is a UK-based psychopharmacology society that mirrors ACNP's focus on brain-behavior-drug research, clinical education, and CME for healthcare professionals. It serves as a regional peer with comparable meeting, publication, and membership programs.
• American College of Psychiatrists: The American College of Psychiatrists is a smaller, honorary psychiatric professional society that overlaps with ACNP in serving distinguished psychiatrist-researchers. It represents an adjacent specialty society with parallel CME and member recognition programs.

Broad incumbents

• Society for Neuroscience: SfN is the largest neuroscience professional society globally, encompassing the broader neuroscience field that includes neuropsychopharmacology. SfN overlaps with ACNP in serving neuroscience researchers but operates at significantly larger scale and with broader scope.
• American Academy of Neurology: AAN is a larger, broader medical specialty society that overlaps with ACNP where neurology and psychiatry intersect (e.g., neuropsychiatric conditions). It serves as a broader incumbent offering CME, journals, and meetings at much larger scale.
• American Psychological Association: APA is the largest professional organization for psychology, adjacent to ACNP's behavioral and psychiatric research focus. APA operates journals, conventions, and continuing education programs comparable in structure but much broader in disciplinary scope.

Emerging players

• Cognitive Neuroscience Society: CNS focuses on cognitive neuroscience with overlapping scientific interests to ACNP's brain-behavior research. While smaller and more research-focused, CNS shares the scientific exchange and publication mission that intersects with ACNP's domain.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/acnporg
• Facebookfacebook.com/american-college-of-neuropsychopharmacology-150012255079741
• LinkedInlinkedin.com/company/acnp

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about American College of Neuropsychopharmacology